Agilus top-line growth remains sluggish
Agilus revenue grew only 3.4% YoY, trailing peers, due to brand transition impact and low-value PPP business decline. Recovery to double-digit growth is uncertain.
medium · analyst_question
Fortis Healthcare Limited — Q2 FY25
Fortis Healthcare delivered a strong Q2 FY25 with consolidated revenue of INR 1,988 crore (+12.3% YoY) and EBITDA of INR 435 crore (+31.9% YoY), driving a 330 bps margin expansi...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Brownfield ramp-up may pressure near-term margins
New bed additions at Manesar and other facilities are expected to initially drag EBITDA, with Manesar break-even estimated at 15 months.
medium · management_commentaryLegal costs remain elevated
Legal costs related to ongoing High Court cases are higher this year due to increased hearings, with no immediate resolution expected.
low · management_commentarySeasonal occupancy dip in Q3
Festival season typically reduces occupancy in Q3, which could impact sequential revenue and margin performance.
low · management_commentary